Naomi Davidson, Ph.D.
Affiliations: | History | University of Ottawa, Ottawa, ON, Canada |
Google:
"Naomi Davidson"Bio:
2007 – Ph.D., History, University of Chicago
2001 – M.A., History, University of Chicago
1998 – B.A., History, Bryn Mawr College
Parents
Sign in to add mentorLeora Auslander | grad student | 2007 | Chicago | |
(Becoming secular? Making Islam French, 1916--1982.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Manohar PM, Davidson NE. (2021) Updates in endocrine therapy for metastatic breast cancer. Cancer Biology & Medicine |
Yung RL, Davidson NE. (2021) Optimal adjuvant endocrine therapy for breast cancer. The Lancet. Oncology. 22: 1357-1358 |
Moy B, Rumble RB, Come SE, et al. (2021) Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101374 |
Aftimos P, Oliveira M, Irrthum A, et al. (2021) Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative. Cancer Discovery |
Vinayak S, Davidson NE. (2021) Selection of Adjuvant Endocrine Therapy for Women with Breast Cancer in Menopausal Transition: Is It Simpler than We Thought? Journal of the National Cancer Institute |
Reis-Filho JS, Davidson NE. (2020) Ki67 Assessment in Breast Cancer: Are We There yet? Journal of the National Cancer Institute |
Hunter NB, Kilgore MR, Davidson NE. (2020) The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical Utility. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Woodward WA, Barlow WE, Jagsi R, et al. (2020) Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. Jama Oncology |
Guenthoer J, Jenkins IC, Thompson B, et al. (2020) Abstract P6-05-03: Exogenous steroid hormone exposure and the biology of lobular breast cancer Cancer Research |
King TA, Liu MC, McClure MB, et al. (2020) Abstract GS3-08: Multiplatform analysis of matched primary and metastatic breast tumors from the AURORA US Network Cancer Research. 80 |